Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. West Pharmaceutical Services, Inc. shares valued at $9,364,409 were purchased by Green Eric Mark on Aug 06 ’24. At $304.71 per share, Green Eric Mark acquired 30,732 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Green Eric Mark sold 30,732 shares, netting a total of over 9,364,409 in proceeds. Following the sale of shares at $304.71 each, the insider now holds 161,898 shares.
Before that, Abraham Silji had sold 1,800 shares from its account. In a trade valued at $595,404, the SVP, Chief Technology Officer traded West Pharmaceutical Services, Inc. shares for $330.78 each. Upon closing the transaction, the insider’s holdings decreased to 1,800 shares, worth approximately $0.84 million.
As published in a research note from Jefferies on February 07, 2024, West Pharmaceutical Services, Inc. [WST] has been rated up from a Hold to a Buy and the price target has been revised to $536 from $323. Analysts at BofA Securities upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in mid June. As of April 11, 2023, Stephens has increased its “an Equal-weight” rating to a “an Overweight” for WST. Earlier on December 14, 2022, Deutsche Bank initiated its rating. Their recommendation was “a Hold” for WST stock.
Analyzing WST Stock Performance
During the last five days, there has been a drop of approximately -3.07%. Over the course of the year, West Pharmaceutical Services, Inc. shares have dropped approximately -16.78%. Shares of the company reached a 52-week high of $413.70 on 02/07/24 and a 52-week low of $265.00 on 07/25/24. A 50-day SMA is recorded $318.33, while a 200-day SMA reached $350.87. Nevertheless, trading volume fell to 0.73 million shares from 0.56 million shares the previous day.
Support And Resistance Levels for West Pharmaceutical Services, Inc. (WST)
According to the 24-hour chart, there is a support level at 289.65, which, if violated, would cause prices to drop to 286.29. In the upper region, resistance lies at 297.89. The next price resistance is at 302.77. RSI (Relative Strength Index) is 39.90 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -3.57, which suggests the price will decrease in the coming days. Percent R is at 53.31%, indicating low price movement. Stochastics%K at holding indicates that the stock is to be held.
